WASHINGTON, April 23 (UPI) -- An ex-Bristol-Myers Squibb Co. executive was indicted Wednesday for allegedly lying to the U.S. government about a deal involving Plavix, prosecutors said.
NEW YORK, June 19 (UPI) -- A federal judge in New York Tuesday upheld the patent on the anti-clotting drug Plavix and barred a generic manufacturer from selling more of its version.
NEW YORK, June 19 (UPI) -- Bristol-Myers Squibb and Sanofi-aventis said Tuesday they have successfully defended their U.S. patent on blood-thinner Plavix against Apotex.
WOODCLIFF LAKE, N.J., April 6 (UPI) -- U.S. generic drug maker Barr said Friday it has initiated a patent challenge to Sanofi-Aventis's sleep drug Ambien.
LONDON, Feb. 12 (UPI) -- U.S. firm Bristol-Myers Squibb and French drug giant Sanofi-Aventis have broken off their merger talks, the Times of London has reported.
NEW YORK, Sept. 1 (UPI) -- Bristol-Myers Squibb and Sanofi-aventis said late Thursday they have successfully enjoined Apotex from making generic Plavix.
NEW YORK, Sept. 1 (UPI) -- A Canadian company says it plans to appeal U.S. court ruling blocking it from distributing a generic version of the anti-clotting drug Plavix.
NEW YORK, Aug. 18 (UPI) -- A hearing got underway Friday, where Bristol-Myers Squibb/Sanofi-Aventis are asking a New York court to stop Apotex's generic Plavix.
TORONTO, Aug. 9 (UPI) -- Apotex Inc., Canada's largest prescription drug maker, has launched a generic version of Plavix, a popular blood-thinner.
NEW YORK, Aug. 4 (UPI) -- U.S. pharmacy benefit managers anticipate greater 2006 profits if as expected a generic form of Plavix hits the market this year, perhaps as soon as this month.
NEW YORK, July 28 (UPI) -- The price tag for Bristol-Myers Squibb Co.'s effort to stave off a Canadian generic rival of its lucrative Plavix blood thinner appears to be rising.
PRAGUE, Czech Republic, March 27 (UPI) -- France's Sanofi-Aventis, the world's No. 3 drug maker, paid $517.9 million for a 25-percent stake in Zentiva, a Czech generic pharmaceutical.
NEW YORK, March 22 (UPI) -- France's Sanofi-aventis and Bristol-Myers Squibb Co. have settled a patent fight with a maker of generic Plavix, a popular blood-thinner.
WOODCLIFF LAKE, N.J., Sept. 7 (UPI) -- Generic versions of allergy drug Allegra will be released to market Thursday despite several patent litigations still winding through the courts.
PARIS, Feb. 18 (UPI) -- The board of French-German drug firm Aventis formally rejected a 46 billion euro ($58.9 billion) hostile bid from French rival Sanofi-Synthelabo.
